Bimekizumab vs Digoxin

## Bimekizumab vs Digoxin: Overview

This comparison examines the pharmacological differences between **Bimekizumab** and **Digoxin**.

## Mechanism of Action

**Digoxin**: Inhibits Na+/K+-ATPase, increasing intracellular calcium.

## Pharmacokinetics

**Half-life**: Bimekizumab — N/A; Digoxin — 36-48 hours.

## Chemical Properties

**Molecular Formula**: Bimekizumab — N/A; Digoxin — C41H64O14.

**Molecular Weight**: Bimekizumab — N/A; Digoxin — 780.9430 g/mol.

**Type**: Bimekizumab — Antibody; Digoxin — Small molecule.